skip to main content

SAT0185 Characteristics of Cytokine Profiles and Prognositc Factors in Interstitial Lung Disease with Polymyositis/Dermatomyositis

Gono, T. ; Kawaguchi, Y. ; Kaneko, H. ; Katsumata, Y. ; Takagi, K. ; Ichida, H. ; Hanaoka, M. ; Baba, S. ; Okamoto, Y. ; Ota, Y. ; Kataoka, S. ; Yamanaka, H.

Annals of the Rheumatic Diseases June 2013, Vol.72(Suppl 3), p.A643 [Periódico revisado por pares]

BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
  • Título:
    SAT0185 Characteristics of Cytokine Profiles and Prognositc Factors in Interstitial Lung Disease with Polymyositis/Dermatomyositis
  • Autor: Gono, T. ; Kawaguchi, Y. ; Kaneko, H. ; Katsumata, Y. ; Takagi, K. ; Ichida, H. ; Hanaoka, M. ; Baba, S. ; Okamoto, Y. ; Ota, Y. ; Kataoka, S. ; Yamanaka, H.
  • É parte de: Annals of the Rheumatic Diseases June 2013, Vol.72(Suppl 3), p.A643
  • Descrição: The complication of interstitial lung disease (ILD) is associated with the anti-aminoacyl tRNA synthetase (aaRS) antibody or the anti-melanoma differentiation-associated gene 5 (MDA5) antibody in polymyositis (PM)/dermatomyositis (DM). Anti-MDA5 antibody is associated with clinically amyopathic DM and fatal outcome due to rapidly progressive (RP) ILD in Asia. The frequency of fatal outcome is 40-50% in RP-ILD with anti-MDA5 antibody. The pathophysiology of ILD has remained unknown sufficiently in PM/DM.
  • Editor: BMJ Publishing Group Ltd and European League Against Rheumatism
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.